CKMT.F Stock Overview
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Carmat SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €12.75 |
| 52 Week High | €12.75 |
| 52 Week Low | €12.75 |
| Beta | 0.94 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -91.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| CKMT.F | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -2.0% | -1.7% |
| 1Y | n/a | 3.1% | 22.4% |
Return vs Industry: Insufficient data to determine how CKMT.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how CKMT.F performed against the US Market.
Price Volatility
| CKMT.F volatility | |
|---|---|
| CKMT.F Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: CKMT.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CKMT.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 171 | Stephane Piat | www.carmatsa.com |
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. It The company was founded in 2008 and is headquartered in Vélizy-Villacoublay, France.
Carmat SA Fundamentals Summary
| CKMT.F fundamental statistics | |
|---|---|
| Market cap | US$215.33m |
| Earnings (TTM) | -US$66.07m |
| Revenue (TTM) | US$2.54m |
84.8x
P/S Ratio-3.3x
P/E RatioIs CKMT.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CKMT.F income statement (TTM) | |
|---|---|
| Revenue | €2.36m |
| Cost of Revenue | €48.43m |
| Gross Profit | -€46.06m |
| Other Expenses | €15.45m |
| Earnings | -€61.51m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
Feb 23, 2023
| Earnings per share (EPS) | -3.14 |
| Gross Margin | -1,949.34% |
| Net Profit Margin | -2,603.00% |
| Debt/Equity Ratio | 366.3% |
How did CKMT.F perform over the long term?
See historical performance and comparison